MSR1 and non-small cell lung carcinoma: In non-small cell lung cancer (NSCLC) 26 and muscle-invasive bladder cancer 27, a higher number of CD204+ TAMs in the stromal area of the tumor is associated with various clinicopathological factors, poor prognosis, and shorter survival time.